|
2025
|
Invention
|
Anti-dectin-2 antibodies.
The invention relates to dendritic cell-associated C-type lectin 2 (De... |
|
|
Invention
|
Aminobenzazepine compounds, immunoconjugates, and uses thereof.
The invention provides immunocon... |
|
2024
|
Invention
|
Anti-dectin-2 antibody combination therapy. The invention relates to a method for treating cancer... |
|
|
Invention
|
Aza-bicyclic sting agonist immunoconjugates, and uses thereof. The invention provides immunoconju... |
|
|
Invention
|
Aza-benzazepine immunoconjugates, and uses thereof. The invention provides immunoconjugates of Fo... |
|
2023
|
Invention
|
Anti-claudin, bis-benzimid azole sting agonist immunoconjugates, and uses thereof. The invention ... |
|
|
Invention
|
Thienoazepine immunoconjugates, and uses thereof. The invention provides immunoconjugates of Form... |
|
|
Invention
|
Cancer combination treatment method. rr or a pharmaceutically acceptable salt thereof, wherein "A... |
|
|
Invention
|
Anti-dectin-2 antibodies and methods of using. The invention relates to dendritic cell-associated... |
|
|
Invention
|
Thienoazepine immunoconjugates, and uses thereof.
The invention provides immunoconjugates of For... |
|
|
Invention
|
Macromolecule-supported 8-sulfonyl-benzazepine compounds and their uses.
The invention provides ... |
|
|
Invention
|
Antibody-conjugated 8-sulfonyl-benzazepine compounds and their uses.
The invention provides immu... |
|
|
Invention
|
Anti-tr0p2, aminobenzazepine immunoconjugates, and uses thereof. The invention provides immunocon... |
|
|
Invention
|
Macromolecule-supported 8-sulfonyl-benzazepine compounds and their uses. The invention provides m... |
|
|
Invention
|
Antibody-conjugated 8-sulfonyl-benzazepine compounds and their uses. The invention provides immun... |
|
2022
|
Invention
|
Tlr agonist immunoconjugates with cysteine-mutant antibodies, and uses thereof. The invention pro... |
|
|
Invention
|
Asymmetric bis-benzimidazole sting agonist immunoconjugates and uses thereof.
The invention prov... |
|
|
Invention
|
Asymmetric bis-benzimidazole sting agonist immunoconjugates and uses thereof. pp, comprising an a... |
|
|
Invention
|
Antibody adjuvant conjugates.
The invention provides an immunoconjugate comprising an antibody c... |
|
|
Invention
|
Immunoconjugates targeting her2.
The invention provides an immunoconjugate of formula:
The inv... |
|
|
Invention
|
Bis-benzimidazole sting agonist immunoconjugates, and uses thereof.
The invention provides immun... |
|
|
Invention
|
Bis-benzimidazole sting agonist immunoconjugates, and uses thereof. The invention provides immuno... |
|
|
Invention
|
2-amino-4-carboxamide-benzazepine immunoconjugates, and uses thereof.
The invention provides imm... |
|
|
Invention
|
2-amino-4-carboxamide-benzazepine immunoconjugates, and uses thereof. The invention provides immu... |
|
2021
|
Invention
|
Anti-cea immunoconjugates, and uses thereof.
The invention provides immunoconjugates of Formula ... |
|
|
Invention
|
Anti-her2 immunoconjugates, and uses thereof.
The invention provides immunoconjugates of Formula... |
|
|
Invention
|
Anti-pd-l1 immunoconjugates, and uses thereof.
The invention provides immunoconjugates of Formul... |
|
|
Invention
|
Immunoconjugates comprising an anti-cea antibody linked by conjugation to one or|more 8-het-2- am... |
|
|
Invention
|
Anti-her2 immunoconjugates, and uses thereof. The invention provides immunoconjugates of Formula ... |
|
|
Invention
|
Anti-pd-l1 immunoconjugates, and uses thereof. The invention provides immunoconjugates of Formula... |
|
|
Invention
|
Anti-cea immunoconjugates, and uses thereof. The invention provides immunoconjugates of Formula I... |
|
|
G/S
|
Biological drug development being pharmaceutical or biopharmaceutical drug development services; ... |
|
|
Invention
|
Antibody adjuvant conjugates. The invention provides an immunoconjugate comprising an antibody co... |
|
|
Invention
|
Pyrazoloazepine immunoconjugates, and uses thereof.
The invention provides immunoconjugates of F... |
|
|
Invention
|
Elastase-substrate, peptide linker immunoconjugates, and uses thereof.
The invention provides im... |
|
|
Invention
|
Cancer treatment methods.
The invention provides methods for treating cancer in a subject compri... |
|
|
Invention
|
Anti-pd-l1 antibodies.
The invention relates to programmed death-ligand 1 (PD-L1) binding agents... |
|
2020
|
G/S
|
Biological drug development and biotechnology research services |
|
|
G/S
|
biological drug development and biotechnology research services. |
|
|
G/S
|
Biological preparations, namely, biopharmaceuticals and biotherapeutics for the treatment of cancer |
|
|
G/S
|
biological preparations. |
|
|
Invention
|
Macromolecule-supported thienoazepine compounds, and uses thereof.
The invention provides macrom... |
|
|
Invention
|
Amide-linked, aminobenzazepine immunoconjugates, and uses thereof.
The invention provides immuno... |
|
|
Invention
|
Immunoconjugate synthesis method.
The invention provides a method for producing an immunoconjuga... |
|
|
Invention
|
Aminoquinoline compounds, immunoconjugates, and uses thereof.
The invention provides immunoconju... |
|
|
G/S
|
biological drug development being pharmaceutical or biopharmaceutical drug development services; ... |
|
|
G/S
|
biological preparations, namely, biopharmaceuticals and biotherapeutics for the treatment of cancer |
|
|
Invention
|
Macromolecule-supported aminobenzazepine compounds.
The application provides macromolecule-suppo... |
|
|
Invention
|
Immunoconjugates targeting her2.
The invention provides an immunoconjugate of formula (I) or (II... |
|
|
Invention
|
Immunoconjugates targeting pd-l1.
The invention provides an immunoconjugate of formula (I) or (I... |
